IL17A and hepatocellular carcinoma: Recently, a number of studies have confirmed the effects of IL-17 on the initiation and development of multiple types of malignancies, including hepatocellular carcinoma [13], lung cancer [14], pancreatic cancer [15], and cervical cancer [16].